Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-{[1-methyl-5-(2-methyl-benzimidazol-1-ylmethyl)-1h-benzimidazol-2-ylmethyl]-amino}-benzamidine
- Development stage
- Unknown
- Lead developer
- Boehringer Ingelheim
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the benzimidazole class, featuring a benzamidine core structure. It is primarily referenced as an experimental or research chemical and does not have established clinical use or approved therapeutic indications. The molecule has been cataloged in chemical and drug databases (e.g., DrugBank DB02354, PubChem CID 445756) but lacks detailed information on its mechanism of action, pharmacological activity, or clinical development status. Its structure suggests potential for biological activity related to benzimidazole derivatives, which are known for diverse pharmacological properties including enzyme inhibition and receptor modulation; however, no specific target or mechanism has been confirmed for this compound[1][3][4][7].
- Other names
- 4-{[1-METHYL-5-(2-METHYL-BENZOIMIDAZOL-1-YLMETHYL)-1H-BENZOIMIDAZOL-2-YLMETHYL]-AMINO}-BENZAMIDINE4-[({1-methyl-5-[(2-methyl-1H-benzodiazol-1yl)methyl]-1H-benzodiazol -2yl}methyl)amino]benzene -carboximidamide
Beyond the preview
Go deeper on 4-{[1-methyl-5-(2-methyl-benzimidazol-1-ylmethyl)-1h-benzimidazol-2-ylmethyl]-amino}-benzamidine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-{[1-methyl-5-(2-methyl-benzimidazol-1-ylmethyl)-1h-benzimidazol-2-ylmethyl]-amino}-benzamidine.